Dr. Jason McKeown is a UK-trained medical doctor with a PhD in Noninvasive Neurostimulation. Through his work in the field of neuroscience and interest in advanced technology, he believes there is a better way to treat diseases affecting the lives of people worldwide. His dedication to advancing medical technology, combined with his deep understanding of diabetes, anxiety, and insomnia, has positioned him as a trailblazer in the field.

In 2016, as a visiting scholar at the University of California Center for Brain & Cognition, Dr. McKeown researched neuroscience and neuromodulation in partnership with Professor V.S. Ramachandran. It was in this lab that the technology behind the Modius products was born. After years of research and development, Dr. McKeown led the Neurovalens team through a successful study into the effectiveness of the Modius Sleep device on the treatment of chronic insomnia, resulting in Medical Device Regulatory Approval from the U.S. FDA in October 2023. In March 2024, Neurovalens also received FDA approval for Modius Stress, a treatment for anxiety.

In April 2024, Dr. McKeown was appointed visiting scholar at the University of California, San Diego (UCSD), in the Department of Psychiatry. Dr. McKeown is an active member of the General Medical Council with the National Health Service in the UK, the Society for Neuroscience with UCSD, and an associate member of the Royal College of Emergency Medicine, the Association of British Neurologists, and the Royal College of Physicians with UCSD.